83 FR 37525 - Importer of Controlled Substances Application: Galephar Pharmaceutical Research Inc.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 83, Issue 148 (August 1, 2018)
Drug Enforcement Administration
Federal Register Volume 83, Issue 148 (August 1, 2018)
| Page Range | 37525-37525 | |
| FR Document | 2018-16466 |
[Federal Register Volume 83, Number 148 (Wednesday, August 1, 2018)] [Notices] [Page 37525] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-16466] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Application: Galephar Pharmaceutical Research Inc. ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 31, 2018. Such persons may also file a written request for a hearing on the application on or before August 31, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been delegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on July 3, 2018, Galephar Pharmaceutical Research Inc., #100 Carr 198 Industrial Park, Juncos, Puerto Rico 00777 applied to be registered as an importer of the following basic class of controlled substance: ------------------------------------------------------------------------ Drug Controlled substance code Schedule ------------------------------------------------------------------------ Hydromorphone.......................... 9150 II ------------------------------------------------------------------------ The company plans to import the listed controlled substance in finished dosage form for clinical trials, research and analytical purposes. Dated: July 23, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018-16466 Filed 7-31-18; 8:45 am] BILLING CODE 4410-09-P
![Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices 37525
Drug respect to the promulgation and Hearing Clerk/LJ, 8701 Morrissette
Controlled substance Schedule
code implementation of 21 CFR part 1301, Drive, Springfield, Virginia 22152; and
incident to the registration of (2) Drug Enforcement Administration,
Phenylacetone ................ 8501 II manufacturers, distributors, dispensers, Attn: DEA Federal Register
Poppy Straw Con- 9670 II importers, and exporters of controlled Representative/DRW, 8701 Morrissette
centrate.
substances (other than final orders in Drive, Springfield, Virginia 22152.
Tapentadol ...................... 9780 II
connection with suspension, denial, or SUPPLEMENTARY INFORMATION: The
revocation of registration) has been Attorney General has delegated his
The company plans to import narcotic
delegated to the Assistant Administrator authority under the Controlled
raw materials to manufacture bulk
of the DEA Diversion Control Division Substances Act to the Administrator of
controlled substances for distribution to
(‘‘Assistant Administrator’’) pursuant to the Drug Enforcement Administration
its customers. The company plans to
section 7 of 28 CFR part 0, appendix to (DEA), 28 CFR 0.100(b). Authority to
import an intermediate form of
subpart R. exercise all necessary functions with
tapentadol (9780), to bulk manufacture In accordance with 21 CFR
tapentadol for distribution to its respect to the promulgation and
1301.34(a), this is notice that on July 3, implementation of 21 CFR part 1301,
customers. 2018, Galephar Pharmaceutical incident to the registration of
Dated: July 23, 2018. Research Inc., #100 Carr 198 Industrial manufacturers, distributors, dispensers,
John J. Martin, Park, Juncos, Puerto Rico 00777 applied importers, and exporters of controlled
Assistant Administrator. to be registered as an importer of the substances (other than final orders in
[FR Doc. 2018–16467 Filed 7–31–18; 8:45 am] following basic class of controlled connection with suspension, denial, or
BILLING CODE 4410–09–P substance: revocation of registration) has been
redelegated to the Assistant
Drug
Controlled substance code Schedule Administrator of the DEA Diversion
DEPARTMENT OF JUSTICE Control Division (‘‘Assistant
Hydromorphone .............. 9150 II Administrator’’) pursuant to section 7 of
Drug Enforcement Administration 28 CFR part 0, appendix to subpart R.
[Docket No. DEA–392] The company plans to import the In accordance with 21 CFR
listed controlled substance in finished 1301.34(a), this is notice that on April
Importer of Controlled Substances dosage form for clinical trials, research 4, 2018, Ultra Scientific Inc., 250 Smith
Application: Galephar Pharmaceutical and analytical purposes. Street, North Kingstown, Rhode Island
Research Inc. Dated: July 23, 2018. 02852 applied to be registered as an
John J. Martin, importer of the following basic classes
ACTION: Notice of application. of controlled substances:
Assistant Administrator.
DATES: Registered bulk manufacturers of [FR Doc. 2018–16466 Filed 7–31–18; 8:45 am] Drug
Controlled substance Schedule
the affected basic classes, and BILLING CODE 4410–09–P code
applicants therefore, may file written
comments on or objections to the Marihuana ....................... 7360 I
DEPARTMENT OF JUSTICE Tetrahydrocannabinols ... 7370 I
issuance of the proposed registration on
or before August 31, 2018. Such persons The company plans to import
Drug Enforcement Administration
may also file a written request for a derivatives of the listed controlled
hearing on the application on or before [Docket No. DEA–392]
substances for use as chemical
August 31, 2018. standards for testing and calibration
Importer of Controlled Substances
ADDRESSES: Written comments should only of analytical equipment. The above
Application: Ultra Scientific Inc.
be sent to: Drug Enforcement controlled substances will not be
Administration, Attention: DEA Federal ACTION: Notice of application. imported for human or animal
Register Representative/DRW, 8701 consumption.
Morrissette Drive, Springfield, Virginia DATES: Registered bulk manufacturers of Dated: July 23, 2018.
22152. All requests for hearing must be the affected basic classes, and
John J. Martin,
sent to: Drug Enforcement applicants therefore, may file written
Administration, Attn: Administrator, Assistant Administrator.
comments on or objections to the
8701 Morrissette Drive, Springfield, issuance of the proposed registration on [FR Doc. 2018–16465 Filed 7–31–18; 8:45 am]
Virginia 22152. All request for hearing or before August 31, 2018. Such persons BILLING CODE 4410–09–P
should also be sent to: (1) Drug may also file a written request for a
Enforcement Administration, Attn: hearing on the application on or before
Hearing Clerk/LJ, 8701 Morrissette August 31, 2018. DEPARTMENT OF JUSTICE
Drive, Springfield, Virginia 22152; and ADDRESSES: Written comments should Drug Enforcement Administration
(2) Drug Enforcement Administration, be sent to: Drug Enforcement
Attn: DEA Federal Register Administration, Attention: DEA Federal [Docket No. DEA–392]
Representative/DRW, 8701 Morrissette Register Representative/DRW, 8701
Drive, Springfield, Virginia 22152. Importer of Controlled Substances
Morrissette Drive, Springfield, Virginia
sradovich on DSK3GMQ082PROD with NOTICES
Application: Anderson Brecon, Inc.
SUPPLEMENTARY INFORMATION: The 22152. All requests for hearing must be
Attorney General has delegated his sent to: Drug Enforcement ACTION: Notice of application.
authority under the Controlled Administration, Attn: Administrator,
Substances Act to the Administrator of 8701 Morrissette Drive, Springfield, DATES: Registered bulk manufacturers of
the Drug Enforcement Administration Virginia 22152. All request for hearing the affected basic classes, and
(DEA), 28 CFR 0.100(b). Authority to should also be sent to: (1) Drug applicants therefore, may file written
exercise all necessary functions with Enforcement Administration, Attn: comments on or objections to the
VerDate Sep<11>2014 20:07 Jul 31, 2018 Jkt 244001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\01AUN1.SGM 01AUN1](https://thefederalregister.org/doc/83_FR_37673/page/1.svg)
Document Created: 2018-08-01 01:22:36
Document Modified: 2018-08-01 01:22:36
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 31, 2018. Such persons may also file a written request for a hearing on the application on or before August 31, 2018. | |
| FR Citation | 83 FR 37525 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR